USPTO serial 79286125
Reviewed by CopyMark Law Group
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Bradley M. Stohry
Bradley M. Stohry Reichel Stohry Dean LLP6151 Central Ave.Indianapolis, IN 46220United States| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software for creating, receiving, manipulating, editing, displaying, storing and organising information, text, data, graphics and images for use in the assessment and diagnosis of brain conditions and brain disease; downloadable computer software for the diagnosis and detection of brain conditions and disease; downloadable computer applications for creating, receiving, manipulating, editing, displaying, storing and organising information, text, data, graphics and images for use in the assessment and diagnosis of brain conditions and brain disease; downloadable computer applications for the diagnosis and detection of brain conditions and disease; downloadable computer software for database management for use in the assessment and diagnosis of brain conditions and brain disease; electronic databases, namely electronic database for the storage of information relating to the assessment and diagnosis of brain conditions and brain disease recorded on computer media; computer databases, namely downloadable electronic databases for the storage of information relating to the assessment and diagnosis of brain conditions and brain disease; downloadable electronic publications, namely, digital patient reports, journals, magazines and newsletters relating to the assessment and diagnosis of brain conditions and brain disease; downloadable computer programs for creating, receiving, manipulating, editing, displaying, storing and organising information, text, data, graphics and images for use in the assessment and diagnosis of brain conditions and brain disease; downloadable computer programs for the diagnosis and detection of brain conditions and disease; downloadable medical diagnostic software for the assessment and diagnosis of brain conditions and brain disease; downloadable diagnostic computer software for the detection of brain conditions and disease; downloadable computer software relating to the medical and healthcare field for the assessment and diagnosis of brain conditions and brain disease; downloadable medical software for the assessment and diagnosis of brain conditions and brain disease; downloadable medical diagnosis, detection and assessment software for the assessment and diagnosis of brain conditions and brain disease; downloadable medical imaging software for the assessment and diagnosis of brain conditions and brain disease; computer documents, namely downloadable documents in the field of the assessment and diagnosis of brain conditions and brain disease provided via a website; computer documentation in electronic form, namely downloadable documents in the field of the assessment and diagnosis of brain conditions and brain disease provided via a website; structural parts and fittings for all of the aforesaid goods | ACTIVE | — |
| 042 | Technological services for medical purposes, namely software as a service (SAAS) services featuring software for use in the assessment and diagnosis of brain conditions and brain disease and scientific research services for medical purposes; laboratory testing of brain tissue samples; laboratory research services in the field of the assessment and diagnosis of brain conditions and brain disease; laboratory analysis in the field of the assessment and diagnosis of brain conditions and brain disease; analytic laboratory services in the field of the assessment and diagnosis of brain conditions and brain disease; medical research in the field of the assessment and diagnosis of brain conditions and brain disease; medical laboratories in the field of the assessment and diagnosis of brain conditions and brain disease; medical sampling services, namely providing laboratory testing of brain tissue samples; healthcare and medical research and development in the field of the assessment and diagnosis of brain conditions and brain disease; clinical research in the field of the assessment and diagnosis of brain conditions and brain disease; conducting clinical trials for others in the field of the assessment and diagnosis of brain conditions and brain disease; providing information on clinical trial studies in the field of the assessment and diagnosis of brain conditions and brain disease; information technology consultancy services for the healthcare and medical industries, namely in the field of the assessment and diagnosis of brain conditions and brain disease; providing information on computer technology and programming via a website, namely in the field of the assessment and diagnosis of brain conditions and brain disease; electronic storage of medical and healthcare information and records; computer programming in the medical and healthcare field, namely in the field of the assessment and diagnosis of brain conditions and brain disease; design and development of medical and healthcare diagnostic apparatus, namely in the field of the assessment and diagnosis of brain conditions and brain disease; design and development of computer software for use with medical and healthcare technology, namely for the assessment and diagnosis of brain conditions and brain disease; providing scientific information in the field of medical disorders and their treatment, namely in the field of the assessment and diagnosis of brain conditions and brain disease; writing of computer programs for medical and healthcare applications, namely in the field of the assessment and diagnosis of brain conditions and brain disease; providing medical and scientific research information in the field of pharmaceuticals and clinical trials, namely in relation to the assessment and diagnosis of brain conditions and brain disease; services for the preparation of scientific and technical reports, namely compiling data for research purposes in the field of the assessment and diagnosis of brain conditions and brain disease; compilation of scientific and technical reports, namely compiling data for research purposes in the field of the assessment and diagnosis of brain conditions and brain disease; design services, namely design for others of computer software for use in the assessment and diagnosis of brain conditions and brain disease; design for others of models for use in the assessment and diagnosis of brain conditions and brain disease; design for others of 3D models for use in the assessment and diagnosis of brain conditions and brain disease; information, advisory and consultancy services in relation to all of the aforementioned services | ACTIVE | — |
| 044 | Performing diagnosis and detection of medical conditions and disease in the field of the assessment and diagnosis of brain conditions and brain disease; performing medical diagnosis and detection of brain conditions and disease; medical and health screening, testing and analysis in the field of the assessment and diagnosis of brain conditions and brain disease; conducting of health assessments, examinations and surveys in the nature of assessments for the diagnosis and detection of brain conditions and disease; medical imaging for the diagnosis and detection of brain conditions and disease; medical analysis services for the assessment and diagnosis of brain conditions and brain disease; analysis and assessment of medical images and scans for the diagnosis and detection of brain conditions and disease; medical testing for the diagnosis and detection of brain conditions and disease; medical services for the diagnosis and detection of brain conditions and disease; services for the preparation, compilation and issuing of medical reports, namely providing medical information to patients in the field of the assessment and diagnosis of brain conditions and brain disease; services for the preparation, compilation and issuing of medical reports, namely providing medical information to patients in the form of reports in the field of brain conditions and disease; provision of medical information in the field of brain conditions and disease; information, advisory and consultancy services in relation to all of the aforementioned services | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| May 20, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 20, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 20, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 3, 2026 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Oct 30, 2025 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 13, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jan 6, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jan 3, 2025 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Dec 29, 2023 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jan 30, 2023 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| May 31, 2022 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Nov 15, 2021 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 27, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 27, 2021 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Oct 25, 2021 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Apr 16, 2021 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 16, 2021 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 16, 2021 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jan 22, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 22, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 22, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 7, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 22, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 22, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 9, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 8, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 30, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 26, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| May 26, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 21, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |